|
10101
|
ENGERIX-B
|
Hepatitis B
|
Hepatitic
|
Hepatitis B virus
|
double stranded DNA
|
DNA based vaccine
|
Approved
|
GlaxoSmithKline
|
NA
|
Rixensart, Belgium
|
All age group
|
3 doses at regimen of 0, 1, and 6 months
|
Intramuscular
|
NA
|
HBsAg
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/engerix-b
|
|
10102
|
RECOMBIVAX HB
|
Hepatitis B
|
Hepatitic
|
Hepatitis B virus
|
double stranded DNA
|
Protein subunit
|
Approved
|
Merck & Co. Inc.
|
NA
|
USA
|
All age group
|
2 doses 6 months apart
|
Intramuscular
|
NA
|
HBsAg
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/recombivax-hb
|
|
10103
|
HEPLISAV-B
|
Hepatitis B
|
Hepatitic
|
Hepatitis B virus
|
double stranded DNA
|
Subunit vaccine
|
Approved
|
Dynavax
|
NA
|
NA
|
18 years and above
|
2 doses 1 month apart
|
Intramuscular
|
CpG
|
HepB
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#vaccFAQ
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/heplisav-b
|
|
10105
|
HBVaxPRO
|
Hepatitis B
|
Hepatitic
|
Hepatitis B virus
|
double stranded DNA
|
Subunit vaccine
|
Approved
|
Sanofi Pasteur
|
NA
|
USA
|
18 years and above
|
NA
|
Intramuscular
|
NA
|
HBsAg
|
NA
|
EMA
|
NA
|
NA
|
NA
|
26208678
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685678/
|
https://www.ema.europa.eu/en/documents/overview/hbvaxpro-epar-summary-public_en.pdf
|
|
10106
|
Fendrix
|
Hepatitis B
|
Hepatitic
|
Hepatitis B virus
|
double stranded DNA
|
NA
|
Approved
|
GlaxoSmithKline
|
NA
|
Belgium
|
NA
|
NA
|
Intradermal, Intravenous
|
AS043
|
HBsAg
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
26208678
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685678/
|
https://www.ema.europa.eu/en/medicines/human/EPAR/fendrix
|